← Leaderboards
Chiara Maria Evans
Weill Medical Coll Of Cornell Univ
$140,482
Attributed
$140,482
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$140,482 · 1
By mechanism
F31$140,482 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Jonathan W. Weinsaft$12,053,026
- Mario Fl Gaudino$5,803,713
- Pascal Spincemaille$5,415,841
- Nathaniel R Campbell$193,830
- Jiwon Kim$4,201,792
Others in their field
Other Emerging Leaders on “Druggable Target”
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
- Kristen A Johnson · California Institute/Biomedical Research$8,530,970
- Sung Han · Salk Institute For Biological Studies$4,868,466
- Brian William Kunkle · University Of Miami School Of Medicine$4,488,849
- William S Bush · Case Western Reserve University$4,488,849
- William Karl Decker · Baylor College Of Medicine$3,693,786
Research focus
Druggable TargetAbl1 GeneAcute Myelocytic LeukemiaDesignAcute Myeloid Leukemia CellArginineAdvanced Malignant NeoplasmBcr-Abl Fusion ProteinsAffectBlood FormationCancer Stem CellCancer TherapyCell CompartmentationCell LineCell MaintenanceCellsCell TransformationChimeric ProteinsBloodCo-ImmunoprecipitationsComplexCrispr ScreenC-TerminalExons
Grant awards (3)
Function of Musashi-2 Methylation in Normal and Malignant Hematopoiesis$47,694
F31 · FY2023 · CA · contact PI
Function of Musashi-2 Methylation in Normal and Malignant Hematopoiesis$46,752
F31 · FY2022 · CA · contact PI
Function of Musashi-2 Methylation in Normal and Malignant Hematopoiesis$46,036
F31 · FY2021 · CA · contact PI